Wayne Winegarden | search
Click here to view Wayne Winegarden news from 60+ newspapers.
Bookmark or Share- The Dangers Hidden In CMS’ Drug Pricing Regulation - ForbesWayne Winegarden. Contributor. Opinions expressed by Forbes Contributors are their own. Wayne Winegarden covers the economic impacts of regulatory policies. Following. Jan 21, 2025, 05:23pm EST.
- WAYNE WINEGARDEN, PH.D - Center for Medical Economics and InnovationWayne Winegarden, Ph.D., is a Sr. Fellow in Business & Economics, Pacific Research Institute, as well as the Director of PRI’s Center for Medical Economics and Innovation.
- People - Pacific Research InstituteWayne Winegarden, Ph.D., is a Sr. Fellow in Business & Economics, Pacific Research Institute, as well as the Director of PRI’s Center for Medical Economics and Innovation.
- The 340B drug discount program is well-intentioned, but must be ...Wayne Winegarden is a senior fellow in business and economics at the Pacific Research Institute.
- Wayne Winegarden - ForbesWayne Winegarden covers the economic implications of regulatory policies. He is a Senior Fellow in Business and Economics at the Pacific Research Institute and Director of the Center...
More
